Article Versions Notes

Dong W, Akasaka I, Komiyama A, Nakamura T, Mizoguchi N, Nawaji T, Ikushiro S, Kobayashi M, Teraoka H. Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish. Pharmaceuticals. 2023; 16(3):368. https://doi.org/10.3390/ph16030368

Dong, Wenjing, Ippo Akasaka, Akifumi Komiyama, Tatsuro Nakamura, Naohiro Mizoguchi, Tasuku Nawaji, Shinichi Ikushiro, Makoto Kobayashi, and Hiroki Teraoka. 2023. "Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish" Pharmaceuticals 16, no. 3: 368. https://doi.org/10.3390/ph16030368

Dong, W., Akasaka, I., Komiyama, A., Nakamura, T., Mizoguchi, N., Nawaji, T., Ikushiro, S., Kobayashi, M., & Teraoka, H. (2023). Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish. Pharmaceuticals, 16(3), 368. https://doi.org/10.3390/ph16030368